| Elder Pharmaceuticals has reported a consolidated total income from operations of Rs 157.93 crore and a net loss of Rs 83.56 crore for the quarter ended Dec '14. | | For the quarter ended Dec 2013 the consolidated total income from operations was Rs 387.07 crore and net loss was Rs 23.34 crore. | | Elder Pharma shares closed at 132.45 on February 13, 2015 (NSE) and has given -20.78% returns over the last 6 months and -30.60% over the last 12 months. |
|
| | Elder Pharmaceuticals | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Dec '14 | Sep '14 | | | Dec '13 | | Net Sales/Income from operations | 156.90 | 200.31 | | | 384.22 | | Other Operating Income | 1.03 | 2.83 | | | 2.85 | | Total Income From Operations | 157.93 | 203.14 | | | 387.07 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 12.57 | 10.63 | | | 19.06 | | Purchase of Traded Goods | 84.54 | 125.85 | | | 186.38 | | Increase/Decrease in Stocks | 10.69 | -3.02 | | | 5.36 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 43.06 | 44.91 | | | 74.13 | | Depreciation | 8.93 | 11.32 | | | 11.07 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 37.60 | 50.34 | | | 68.62 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -39.45 | -36.90 | | | 22.44 | | Other Income | 0.94 | 9.32 | | | 4.37 | | P/L Before Int., Excpt. Items & Tax | -38.51 | -27.57 | | | 26.82 | | Interest | 45.05 | 23.18 | | | 49.35 | | P/L Before Exceptional Items & Tax | -83.56 | -50.76 | | | -22.53 | | Exceptional Items | -- | 4.03 | | | -0.48 | | P/L Before Tax | -83.56 | -46.72 | | | -23.01 | | Tax | -- | 0.15 | | | 0.32 | | P/L After Tax from Ordinary Activities | -83.56 | -46.87 | | | -23.34 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -83.56 | -46.87 | | | -23.34 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -- | -- | | | -- | | Net P/L After M.I & Associates | -83.56 | -46.87 | | | -23.34 | | Equity Share Capital | 20.54 | 20.54 | | | 20.54 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -40.69 | -22.82 | | | -11.36 | | Diluted EPS | -40.69 | -22.82 | | | -11.36 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -40.69 | -22.82 | | | -11.36 | | Diluted EPS | -40.69 | -22.82 | | | -11.36 | | Public Share Holding | | | | | | | No Of Shares (Crores) | -- | 1.48 | | | 1.52 | | Share Holding (%) | -- | 72.12 | | | 74.00 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | -- | 0.45 | | | 0.51 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | 77.73 | | | 95.30 | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | 21.67 | | | 24.77 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | -- | 0.13 | | | 0.03 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | 22.27 | | | 1.23 | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | 6.21 | | | 4.70 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
